STAMFORD, Conn., Feb. 13, 2025 /PRNewswire/ — Olympus Partners has acquired PAI Pharma (“PAI”), the leading developer, manufacturer and distributor of generic oral liquids in both ready-to-dose cups and bottles in the United States. PAI offers the broadest portfolio of generic oral…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.